Anissa Roger

INSERM U976 Hôpital Saint Louis 1 Avenue Claude Vellefaux
Paris, 75010, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

PDE4D drives rewiring of the MAPK pathway in BRAF-mutated melanoma resistant to MAPK inhibitors.

PDE4D drives rewiring of the MAPK pathway in BRAF-mutated melanoma resistant to MAPK inhibitors.

Journal: Cell communication and signaling : CCS

Published: June 25, 2024

Reply to A. Ruggiero et al. to our article 'Impact of the French COVID-19 pandemic lockdown on newly diagnosed melanoma delay and severity'.

Reply to A. Ruggiero et al. to our article 'Impact of the French COVID-19 pandemic lockdown on newly diagnosed melanoma delay and severity'.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: July 21, 2022

Efficacy of Large Use of Combined Hypofractionated Radiotherapy in a Cohort of Anti-PD-1 Monotherapy-Treated Melanoma Patients.

Efficacy of Large Use of Combined Hypofractionated Radiotherapy in a Cohort of Anti-PD-1 Monotherapy-Treated Melanoma Patients.

Journal: Cancers

Published: July 13, 2022

Formalin-fixed tissue Mohs surgery (slow Mohs) for trichoblastic carcinoma.

Formalin-fixed tissue Mohs surgery (slow Mohs) for trichoblastic carcinoma.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: February 21, 2022

Impact of the French COVID-19 pandemic lockdown on newly diagnosed melanoma delay and severity.

Impact of the French COVID-19 pandemic lockdown on newly diagnosed melanoma delay and severity.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: August 25, 2021

Immune-Related Erythema Nodosum Mimicking in Transit Melanoma Metastasis on [18F]-FDG PET/CT.

Immune-Related Erythema Nodosum Mimicking in Transit Melanoma Metastasis on [18F]-FDG PET/CT.

Journal: Diagnostics (Basel, Switzerland)

Published: March 18, 2021

Which adjuvant treatment for patients with BRAFV600-mutant cutaneous melanoma?

Which adjuvant treatment for patients with BRAFV600-mutant cutaneous melanoma?

Journal: Annales de dermatologie et de venereologie

Published: June 11, 2020

Efficacy of late concurrent hypofractionated radiotherapy in advanced melanoma patients failing anti-PD-1 monotherapy.

Efficacy of late concurrent hypofractionated radiotherapy in advanced melanoma patients failing anti-PD-1 monotherapy.

Journal: International journal of cancer

Published: August 06, 2019

Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) induced by immune checkpoint inhibitors.

Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) induced by immune checkpoint inhibitors.

Journal: Annals of the rheumatic diseases

Published: May 31, 2018

Efficacy of combined hypo-fractionated radiotherapy and anti-PD-1 monotherapy in difficult-to-treat advanced melanoma patients.

Efficacy of combined hypo-fractionated radiotherapy and anti-PD-1 monotherapy in difficult-to-treat advanced melanoma patients.

Journal: Oncoimmunology

Published: November 20, 2017

Status of the SPIRAL2 injector commissioning.

Status of the SPIRAL2 injector commissioning.

Journal: The Review of scientific instruments

Published: March 03, 2016

Leg ulcers occurring under tyrosine kinase inhibitor therapy (sunitinib, nilotinib)

Leg ulcers occurring under tyrosine kinase inhibitor therapy (sunitinib, nilotinib)

Journal: Annales de dermatologie et de venereologie

Published: December 29, 2015

Showing 1-12 of 13

Last Updated: 09/26/2026